ANIX Stock Price History and Quote Analysis Insights for Investors
Anixa Biosciences, Inc.
Stock Price Today
Anixa Biosciences, Inc. (ANIX) stock declined over -2.41%, trading at $3.24 on NASDAQ, down from the previous close of $3.32. The stock opened at $3.35, fluctuating between $3.24 and $3.43 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Company Information
| Employees | 4 |
| Beta | 0.85 |
| Sales or Revenue | $210.00K |
| 5Y Sales Change% | -0.893% |
| Fiscal Year Ends | October |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Anixa Biosciences, Inc. (NASDAQ: ANIX) stock price is $3.24 in the last trading session. During the trading session, ANIX stock reached the peak price of $3.43 while $3.24 was the lowest point it dropped to. The percentage change in ANIX stock occurred in the recent session was -2.41% while the dollar amount for the price change in ANIX stock was -$0.08.
The NASDAQ listed ANIX is part of Biotechnology industry that operates in the broader Healthcare sector. Anixa Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Pamela D. Garzone Ph.D.
Chief Devel. Officer & Chair Breast Cancer Clinical Advisory Board
Dr. Amit Kumar Ph.D.
Chairman & Chief Executive Officer
Mr. Michael J. Catelani CPA, MBA
Pres, Chief Operating Officer, Chief Financial Officer & Corporation Sec.
Mr. John Roop
Senior Vice President of Engineering
ANIX's closing price is 50.7% higher than its 52-week low of $2.15 where as its distance from 52-week high of $5.13 is -36.84%.
Number of ANIX employees currently stands at 4.
Official Website of ANIX is: https://www.anixa.com
ANIX could be contacted at phone 408 708 9808 and can also be accessed through its website. ANIX operates from 3150 Almaden Expressway, San Jose, CA 95118, United States.
ANIX stock volume for the day was 140.32K shares. The average number of ANIX shares traded daily for last 3 months was 86.54K.
The market value of ANIX currently stands at $104.26M with its latest stock price at $3.24 and 32.18M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com